<DOC>
	<DOC>NCT01157377</DOC>
	<brief_summary>This study will evaluate the safety and efficacy of AGN-214868 in patients with idiopathic overactive bladder (IOAB) and urinary incontinence.</brief_summary>
	<brief_title>Safety and Efficacy Study of AGN-214868 in Patients With Idiopathic Overactive Bladder and Urinary Incontinence</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder, Overactive</mesh_term>
	<criteria>If female, must be of nonreproductive potential If male, must agree to use acceptable contraception Symptoms of overactive bladder with urinary urgency incontinence Inadequate response or limiting side effects with anticholinergics for the treatment of OAB Overactive bladder caused by neurological condition (eg, spinal cord injury, multiple sclerosis) History of bladder surgery Treatment with botulinum toxin therapy of any serotype for any nonurological condition within the prior 12 weeks Previous treatment with botulinum toxin therapy of any serotype for any urological condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>